Dr. Brad Anderson is a Professor in Pharmaceutical Sciences at the College of Pharmacy, University of Kentucky. Dr. Anderson received his M.S. and Ph.D. in Pharmaceutical Chemistry from the University of Kansas in 1978. He spent the next five years as a research scientist at The Upjohn Co. for 5 years before joining the University of Utah in 1983 as an Associate Professor in Pharmaceutics and Pharmaceutical Chemistry. Dr. Anderson relocated to the University of Kentucky in 2000 where he served as Chair of the Pharmaceutical Sciences department until 2003 and as Interim Chair in 2012-13. He is a Charter Member of the AAPS and an AAPS Fellow. He has received several awards throughout his career including the Pfizer Young Investigator Award (1985), the Meritorious Manuscript Award from Pharm. Res. (1990), the Outstanding Paper Award in J. Controlled Release (1992), the Ebert Prize for the best paper in J. Pharm. Sci. (1998), the University of Utah Distinguished Research Award (1999), the AAPS Dale E. Wurster Research Award in Pharmaceutics (2012), and the AAPS Outstanding Educator Award (2016). Anderson serves on several editorial advisory boards and is an Editor for J. Pharm. Sci. He holds several patents in prodrug design and drug delivery system design and has approximately 160 publications in drug solubilization and stabilization, prodrug design and drug targeting for the treatment of cancer and AIDS, lipid bilayer transport and liposomal drug delivery, and computational methods for predicting membrane transport and drug formulation properties. His current research interests include lipid bilayer membrane transport, controlled drug-delivery to solid tumors using nanotechnology, chemical stability in amorphous solid-state formulations, and molecular dynamics simulations to explore the properties of drugs in amorphous formulations.